Stay updated on Tau Vaccine Safety in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page.

Latest updates to the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Alzheimer's Disease, while retaining the mention of collaborators and the principal investigator.SummaryDifference27%
- Check39 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 14, 2025.SummaryDifference0.4%
- Check46 days agoChange DetectedThe page has been updated to reflect a new revision number (v2.14.3) and a new last update date (March 25, 2025), replacing the previous estimated dates and revision number.SummaryDifference0.3%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check90 days agoChange DetectedThe webpage has been updated to include new results and assessments related to Treatment-Emergent Adverse Events (TEAEs) and various health metrics, while several previous data points and results have been removed.SummaryDifference53%
Stay in the know with updates to Tau Vaccine Safety in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page.